Frailty and checkpoint inhibitor toxicity in older patients with melanoma-Reference-Cited by-同舟云学术

Frailty and checkpoint inhibitor toxicity in older patients with melanoma

Published:2022-04-19 Issue:14 Volume:128 Page:2746-2752
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bruijnen Cheryl P.¹^ORCID,Koldenhof José J.¹^ORCID,Verheijden Rik J.¹,van den Bos Frederiek²,Emmelot‐Vonk Mariëlle H.³,Witteveen Petronella O.¹,Suijkerbuijk Karijn P. M.¹

Affiliation:

1. Department of Medical Oncology University Medical Center Utrecht Utrecht the Netherlands

2. Department of Geriatrics Leiden University Medical Center Leiden the Netherlands

3. Department of Geriatrics University Medical Center Utrecht Utrecht the Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34230

Reference45 articles.

1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

2. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

3. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs

4. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group;Cancers;2024-09-09

2. Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study;Journal of Geriatric Oncology;2024-09

3. Geriatric Assessment in the Era of Targeted and Immunotherapy;Drugs & Aging;2024-06-24

4. Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study;Cancer Immunology, Immunotherapy;2024-05-11

5. Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis;Frontiers in Oncology;2024-05-10